Works matching IS 17762596 AND DT 2015 AND VI 10 AND IP 3

Results: 14

Targeting epidermal growth factor receptors and downstream signaling pathways in cancer by phytochemicals.

Published in:

Targeted Oncology, 2015, v. 10, n. 3, p. 337, doi. 10.1007/s11523-014-0339-4

By:

Kadioglu, Onat;
Cao, Jingming;
Saeed, Mohamed;
Greten, Henry;
Efferth, Thomas

Publication type:

Article

Comparison of tyrosine kinase receptors HER2, EGFR, and VEGFR expression in micropapillary urothelial carcinoma with invasive urothelial carcinoma.

Published in:

Targeted Oncology, 2015, v. 10, n. 3, p. 355, doi. 10.1007/s11523-014-0341-x

By:

Li, Jianhong;
Jackson, Cynthia;
Yang, Dongfang;
Noble, Lelia;
Wheeler, Michael;
MacKenzie, Dolores;
Adegun, Temitope;
Amin, Ali

Publication type:

Article

Receptors for luteinizing hormone-releasing hormone (GnRH) as therapeutic targets in triple negative breast cancers (TNBC).

Published in:

Targeted Oncology, 2015, v. 10, n. 3, p. 365, doi. 10.1007/s11523-014-0340-y

By:

Kwok, C.;
Treeck, O.;
Buchholz, S.;
Seitz, S.;
Ortmann, O.;
Engel, J.

Publication type:

Article

Panitumumab as a radiosensitizing agent in KRAS wild-type locally advanced rectal cancer.

Published in:

Targeted Oncology, 2015, v. 10, n. 3, p. 375, doi. 10.1007/s11523-014-0342-9

By:

Mardjuadi, Feby;
Carrasco, Javier;
Coche, Jean-Charles;
Sempoux, Christine;
Jouret-Mourin, Anne;
Scalliet, Pierre;
Goeminne, Jean-Charles;
Daisne, Jean-François;
Delaunoit, Thierry;
Vuylsteke, Peter;
Humblet, Yves;
Meert, Nicolas;
Eynde, Marc;
Moxhon, Anne;
Haustermans, Karin;
Canon, Jean-Luc;
Machiels, Jean-Pascal

Publication type:

Article

Prognostic factors in renal cell carcinoma patients treated with sorafenib: results from the Czech registry.

Published in:

Targeted Oncology, 2015, v. 10, n. 3, p. 385, doi. 10.1007/s11523-014-0343-8

By:

Kubackova, Katerina;
Bortlicek, Z.;
Pavlik, T.;
Melichar, B.;
Linke, Z.;
Pokorna, P.;
Vyzula, R.;
Prausova, J.;
Buchler, T.

Publication type:

Article

Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition.

Published in:

Targeted Oncology, 2015, v. 10, n. 3, p. 393, doi. 10.1007/s11523-014-0344-7

By:

Coco, Simona;
Truini, Anna;
Alama, Angela;
Dal Bello, Maria;
Venè, Roberta;
Garuti, Anna;
Carminati, Enrico;
Rijavec, Erika;
Genova, Carlo;
Barletta, Giulia;
Sini, Claudio;
Ballestrero, Alberto;
Boccardo, Francesco;
Grossi, Francesco

Publication type:

Article

Targeted delivery of siRNA using transferrin-coupled lipoplexes specifically sensitizes CD71 high expressing malignant cells to antibody-mediated complement attack.

Published in:

Targeted Oncology, 2015, v. 10, n. 3, p. 405, doi. 10.1007/s11523-014-0345-6

By:

Cinci, Marc;
Mamidi, Srinivas;
Li, Wenhan;
Fehring, Volker;
Kirschfink, Michael

Publication type:

Article

Colorectal liver metastases are more often super wild type. Toward treatment based on metastatic site genotyping?

Published in:

Targeted Oncology, 2015, v. 10, n. 3, p. 415, doi. 10.1007/s11523-014-0346-5

By:

Allard, M.;
Saffroy, R.;
Maisonneuve, P.;
Ricca, L.;
Bosselut, N.;
Hamelin, J.;
Lecorche, E.;
Bejarano, M.;
Innominato, P.;
Sebagh, M.;
Adam, R.;
Morère, J.;
Lemoine, A.

Publication type:

Article

Everolimus in patients with metastatic renal cell carcinoma previously treated with bevacizumab: a prospective multicenter study CRAD001LRU02T.

Published in:

Targeted Oncology, 2015, v. 10, n. 3, p. 423, doi. 10.1007/s11523-014-0347-4

By:

Tsimafeyeu, Ilya;
Snegovoy, Anton;
Varlamov, Sergei;
Safina, Sufia;
Varlamov, Ilya;
Gurina, Ludmila;
Manzuk, Ludmila

Publication type:

Article

Association of drug exposure with toxicity and clinical response in metastatic renal cell carcinoma patients receiving an attenuated dosing regimen of sunitinib.

Published in:

Targeted Oncology, 2015, v. 10, n. 3, p. 429, doi. 10.1007/s11523-014-0349-2

By:

Teo, Yi;
Chue, Xiu;
Chau, Noan;
Tan, Min-Han;
Kanesvaran, Ravindran;
Wee, Hwee;
Ho, Han;
Chan, Alexandre

Publication type:

Article

Sunitinib does not attenuate contractile force following a period of ischemia in isolated human cardiac muscle.

Published in:

Targeted Oncology, 2015, v. 10, n. 3, p. 439, doi. 10.1007/s11523-014-0351-8

By:

Thijs, Anna;
El Messaoudi, Saloua;
Vos, Johanna;
Wouterse, Alfons;
Verweij, Vivienne;
Swieten, Henry;
Herpen, Carla;
Graaf, Winette;
Noyez, Luc;
Rongen, Gerard

Publication type:

Article

Regorafenib: start low and go slow.

Published in:

Targeted Oncology, 2015, v. 10, n. 3, p. 445, doi. 10.1007/s11523-014-0352-7

By:

Tabchi, S.;
Ghosn, M.

Publication type:

Article

The route to personalized medicine in bladder cancer: where do we stand?

Published in:

Targeted Oncology, 2015, v. 10, n. 3, p. 325, doi. 10.1007/s11523-015-0357-x

By:

Massari, Francesco;
Ciccarese, Chiara;
Santoni, Matteo;
Brunelli, Matteo;
Conti, Alessandro;
Modena, Alessandra;
Montironi, Rodolfo;
Santini, Daniele;
Cheng, Liang;
Martignoni, Guido;
Cascinu, Stefano;
Tortora, Giampaolo

Publication type:

Article

Treatment of advanced thyroid cancer: role of molecularly targeted therapies.

Published in:

Targeted Oncology, 2015, v. 10, n. 3, p. 311, doi. 10.1007/s11523-014-0331-z

By:

Covell, Lorinda;
Ganti, Apar

Publication type:

Article